Farmadoks Healthcare Ltd. (quality control/testing)
UkraineAll drugs from this manufacturer
-
The drug is prescribed for the treatment of non-small cell lung cancer (as first-line therapy in the presence of certain mutations, for maintenance therapy, or after ineffective chemotherapy), as well as for the treatment of metastatic pancreatic cancer in combination with gemcitabine.
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 100 mg ATC: L01EB02
-
The drug is used for the treatment of non-small cell lung cancer (as first-line therapy, for maintenance therapy, or after ineffective chemotherapy) and metastatic pancreatic cancer (in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 150 mg ATC: L01EB02